Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.36 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.32 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 2/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3763441 | 0.92 | CYSLTR2 (0.38) | CTSSCTSKCTSLTAAR1RPS6KA1 | |
| SCHEMBL3771175 | 0.90 | CYSLTR2 (0.42) | CTSSCTSKCTSLCYSLTR2CYSLTR1 | |
| SCHEMBL3766158 | 0.88 | CYP1A2 (0.35) | TAAR1RPS6KA1MAOBMAPTL3MBTL1 | |
| SCHEMBL3768083 | 0.88 | TAAR1 (0.38) | CTSSCTSKCTSLTAAR1RPS6KA1 | |
| SCHEMBL3766396 | 0.87 | L3MBTL1 (0.39) | RPS6KA1MAPTL3MBTL1 | |
| SCHEMBL3764641 | 0.83 | TAAR1 (0.39) | CTSSCTSKCTSLTAAR1RPS6KA1 | |
| SCHEMBL3764583 | 0.80 | CYP1A2 (0.40) | MAPTL3MBTL1KDM4E | |
| SCHEMBL3772715 | 0.79 | RPS6KA1 (0.34) | TAAR1RPS6KA1MAOBMAPTL3MBTL1 | |
| SCHEMBL3769102 | 0.78 | CTSL (0.35) | CTSSCTSKCTSLCYSLTR2CYSLTR1 | |
| SCHEMBL3660887 | 0.78 | CTSL (0.35) | CTSSCTSKCTSLCYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | SUMITOMO CHIEMCAL COMPANY LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311790-A1 | AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME | ATL3, NAT1, C5 | CTSS 2078/4885CTSK 3257/4885CTSL 4124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.